NCNA_OUT_1 [2025-04-01 07:19:45 -0400] 2368 Bytes | 701 tokens | Cum: 701 tkns (8.76% of 8k)
==========================================================================

We're scouting for winners today. Its 7:19:45 AM on Tue Apr 01, 2025 -0400 and I'm looking at NuCana (NCNA) up to 0.9975 from 0.8728

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for NuCana:

C1 - Mar-20-25 04:01PM - NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
C2 - Nov-25-24 07:00AM - NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
C3 - Nov-11-24 07:00AM - NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
C4 - Oct-04-24 01:03PM - Baillie Gifford's Strategic Acquisition of NuCana PLC Shares
C5 - Sep-25-24 04:01PM - NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
C6 - Sep-16-24 09:24AM - NuCana's Encouraging Data From Resistant Melanoma Treatment Provides Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
C7 - Sep-14-24 03:01AM - NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
C8 - Aug-30-24 08:47AM - NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data

Prior AI Reports for NCNA:
1. 2025-03-27 – Score: 60 – Target: 1.6000 – Highs: 1.1000 / 1.3400 / 1.33
companys-short-term-gain-overshadows-long-term-concerns

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on NuCana (NCNA)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

NCNA_OUT_3 [2025-04-01 07:19:50 -0400] 1099 Bytes | 341 tokens | Cum: 1044 tkns (13.05% of 8k)
==========================================================================

Showing C1 (chunk 1 of 12): C1:
**NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update**
Date: Mar-20-25 04:01PM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/20/3046697/0/en/NuCana-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results-and-Provides-Business-Update.html

March 20, 2025 16:01 ET| Source:NuCana plcNuCana plc

Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025

Data from the Expansion Study to Support Interaction with FDA and Define Regulatory Strategy for NUC-7738

Data from the Ongoing Phase 1b/2 Study of NUC-3373 in Combination with Pembrolizumab

EDINBURGH, United Kingdom, March 20, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced financial results for the fourth quarter and year ended December 31, 2024

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

NCNA_OUT_5 [2025-04-01 07:19:51 -0400] 1026 Bytes | 288 tokens | Cum: 1450 tkns (18.12% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T12:56:29Z - Market Outlook: What To Expect This Week - eBay (NASDAQ:EBAY), American International Gr (NYSE:AIG)...
A2 - 2025-03-20T20:25:06Z - NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update...
A3 - 2025-03-20T20:01:49Z - NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update - NuC...
A4 - 2025-03-20T20:10:00Z - NuCana plc: NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business ...
A5 - 2025-03-20T20:08:23Z - NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

NCNA_OUT_7 [2025-04-01 07:19:53 -0400] 321 Bytes | 94 tokens | Cum: 1546 tkns (19.32% of 8k)
==========================================================================

Showing A1 (chunk 1 of 1):

[INFO] Your document request exceeded 20000 characters. If you need more, please request additional documents separately.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

NCNA_OUT_9 [2025-04-01 07:19:54 -0400] 959 Bytes | 294 tokens | Cum: 1899 tkns (23.74% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-08-15T20:01:00Z - NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
B2 - 2024-05-30T12:36:00Z - NuCana to Present at the Jefferies Global Healthcare Conference
B3 - 2024-05-21T12:00:00Z - NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
B4 - 2024-05-16T20:01:00Z - NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
B5 - 2024-05-01T20:01:00Z - NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
B6 - 2024-04-09T20:30:00Z - NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

NCNA_OUT_11 [2025-04-01 07:19:57 -0400] 741 Bytes | 224 tokens | Cum: 2125 tkns (26.56% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/08/15/2931230/0/en/NuCana-Reports-Second-Quarter-2024-Financial-Results-and-Provides-Business-Update.htmlNuCana reported a net loss of £7.0 million for Q2 2024 and had £11.6 million in cash as of June 30, 2024. The company is advancing its clinical programs, including NUC-3373 and NUC-7738, and expects to announce data readouts in the second half of 2024.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

NCNA_OUT_13 [2025-04-01 07:19:58 -0400] 238 Bytes | 59 tokens | Cum: 2265 tkns (28.31% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

NCNA_OUT_15 [2025-04-01 07:20:07 -0400] 3250 Bytes | 835 tokens | Cum: 3103 tkns (38.79% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+----------------------+
| Volume: 372,584 | Perf Month: -10.02% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+--------------------+-----------------------+------------------------+----------------------+
| Avg Volume: 87.68K | Perf Quarter: -34.38% | Short Float: 0.17% | ROE: -183.07% |
+--------------------+-----------------------+------------------------+----------------------+
| Rel Volume: 3.36 | Index: - | Short Ratio: 0.10 | ROI: -318.25% |
+--------------------+-----------------------+------------------------+----------------------+
| RSI (14): 48.01 | Market Cap: 4.94M | Short Interest: 0.01M | Sales Surprise: - |
+--------------------+-----------------------+------------------------+----------------------+
| ATR (14): 0.14 | Shs Outstand: 5.66M | Beta: 1.47 | EPS Surprise: 86.54% |
+--------------------+-----------------------+------------------------+----------------------+
| SMA20: 0.15% | Shs Float: 5.33M | Sales Q/Q: - | P/E: - |
+--------------------+-----------------------+------------------------+----------------------+
| SMA50: -8.60% | Inst Own: 5.88% | Sales past 5Y: 0.00% | Earnings: Mar 20 AMC |
+--------------------+-----------------------+------------------------+----------------------+
| SMA200: -60.53% | Insider Own: 5.88% | Employees: 22 | |
+--------------------+-----------------------+------------------------+----------------------+
| Perf Week: 10.48% | Insider Trans: 0.00% | Debt/Eq: 0.03 | |
+--------------------+-----------------------+------------------------+----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.8728
Average Volume: 111596.48
30-Day High: 1.28
30-Day Low: 0.7605
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

NCNA_OUT_17 [2025-04-01 07:20:09 -0400] 676 Bytes | 167 tokens | Cum: 3488 tkns (43.60% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

NCNA_IN_19 [2025-04-01 07:20:09 -0400] 126 Bytes | 29 tokens | Cum: 3545 tkns (44.31% of 8k)
==========================================================================

====================================
[2025-04-01 07:20:09] # Analysis Completed
Elapsed Time: 24.44 seconds